Buscar
Congreso SOLACI
HomeInternational CongressesEuroPCR 2015.

EuroPCR 2015.

Ver Categoría
Day 2

ILUMIEN I: Results of the angioplasty indicated by FFR and controlled by OCT

This is an observational, prospective, multicenter study using optical coherence tomography (OCT) and measurement of fractional flow...
solaci -
Ver más
Day 2

SAPIENS 3: Favorable outcomes with TAVI in intermediate risk patients

Transcatheter aortic valve replacement is a safe and effective alternative to surgery in patients with severe aortic...
solaci -
Ver más
Day 2

ILUMIEN II: OCT guided stenting versus IVUS

The main predictor of adverse outcomes (thrombosis and restenosis) after implantation of a stent is the degree...
solaci -
Ver más
Day 2

ADVANCE II CoreValve Trial: Results at six months of self-expanding aortic valve

The CoreValve ADVANCE II Trial is a research study of the best practices to implement this device....
solaci -
Ver más
Day 2

BVS-STEMI-FIRST OCT study: Bioabsorbable platform in acute myocardial infarction

A bioabsorbable platform implant in the context of ST segment elevation acute myocardial infarction is feasible although...
solaci -
Ver más
Day 2

CoreValve Evolut R CE: Good results at 6 months of the new CoreValve repositionable

This study evaluated the safety and efficacy of the new repositionable self-expanding valve. The primary end point...
solaci -
Ver más
Day 2

OPINION: optical frequency domain versus IVUS to guide angioplasty

This multicenter, prospective, randomized controlled study was designed to evaluate the noninferiority of guided angioplasty by optical...
solaci -
Ver más
Day 1

Estudo FFRCT RIPCORD: a FFR derivada da angiotomografia de coronárias pode mudar a estratégia terapêutica?

Fundamentos e objetivos:  A reserva de fluxo fracionada (FFR) Invasiva é uma ferramenta bem validada e reprodutível...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

Dr. Omar Tupayachi - 0
TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

Dr. Omar Tupayachi - 0
The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

Dr. Omar Tupayachi - 0
The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

Noticias Institucionales

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

solaci - 0
We are now open for registration to the hybrid training course on Hemodynamics and Interventional Cardioangiology for Technicians and Nurses SOLACI-CACI 2025 Find all course...

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad